Purpose: This study proposed a synchronous measurement method for patient-specific dosimetry using two three-dimensional dose verification systems with delivery errors.
Methods: Twenty hypofractionated radiotherapy treatment plans for patients with lung cancer were retrospectively reviewed. Monitor unit (MU) changes, leaf in-position errors, and angles of deviation of the collimator were intentionally introduced to investigate the detection sensitivity of the EDose + EPID (EE) and Dolphin + Compass (DC) systems.
Results: Both systems accurately detected the MU modifications and had a similar ability to detect leaf in-position errors. The detection of multi-leaf collimator (MLC) errors was difficult for the whole body using different gamma criteria. When the introduced MLC error was 1.0 mm, the numbers of errors detected in the clinical target volume (CTV) by the EE system were 20, 20, and 20 and the numbers of errors detected by the DC system were 18, 19, and 20, at 3%/2 mm, 2%/2 mm, and 1%/1 mm, respectively. The average dose deviation of all DVH parameters exceeded 3%. The gamma and DVH evaluation results remained unchanged for the DC system when different collimator angle errors were introduced. The number of errors detected by the EE system was <11 for each anatomical structure for all gamma criteria. The mean dose deviation of the CTV was not distinguished.
Conclusions: This synchronous measurement approach can effectively eliminate the influence of random errors during treatment. The EE and DC systems reconstruct the three-dimensional dose distribution accurately and are convenient and reliable for dose verification.
Keywords: Cross-validation; Dolphin detector; EPID; Three-dimensional dose verification.
Copyright © 2021 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.